Skip to Main Content

March 17, 2023    
Health Law Weekly

Pfizer to Expand Oncology Business with $43 Billion Acquisition of Biotech Seagen

  • March 17, 2023

Pharmaceutical giant Pfizer Inc. is planning to acquire oncology-focused biotechnology firm Seagen Inc. in a deal valued at $43 billion, the companies announced March 13.


You must be logged in to access this content.